They want to treat degenerative and oncologic conditions. CYTX-Cytori Therapeutics-NASDAQĬytori Therapeutics deals in specialty therapeutics combining nanoparticle and proprietary cell therapy platforms. They have their own technology using mesenchymal stem cells. CLBS-Caladrius Biosciences-NASDAQĬaladrius has three different products to treat autoimmune and cardiovascular diseases. They develop and commercialize medicines for inflammatory disorders and cancer. Their technology uses umbilical cord cells. CCEL-Cryo-Cell International-OTCQBĬCEL is hoping to make advances in regenerative medicine with the cryo-preservation of stem cells. They’re also looking to treat osteoarthritis. They develop immunotherapies for cancer patients and also develop stem cell therapies for degenerative problems. They discover, develop, and commercialize first-class therapeutics in the biological field. They’re also looking into treating metabolic disorders. This company is developing stem cell treatments for disc degeneration in chronic back pain. It is focused on ground-breaking research in the field of nanotechnology and is pursuing exosomes and other micro vesicles as the next frontier in stem cell-based therapeutics. Organicell is an integrated exosome therapeutics company. BPSR-Organicell Regenerative Medicine Inc-OTC BLUE-bluebird bio-NASDAQīluebird Bio develops gene therapies. BSEM-Biostem Technologies Inc-OTCīioStem Technologies develops amniotic membrane and umbilical cord tissue derived products for use in regenerative medicine, including: RHEO™, OROPRO™, VENDAJE™ and VENDAJE™ OPTIC. such as MS, Huntington’s Disease, and Parkinson’s among others. They have a wide array of products looking to fight ALS and other neurodegenerative diseases. BCDA-Biocardia-NASDAQīiocardia is a company that is involved with medicine for cardiovascular issues. ATHX-Athersys-NASDAQĪrthersys is hoping to treat ischemic stroke, neurological disease, cardiovascular problems, and immune and inflammatory diseases. They also import, export, and develop pharmaceutical products. ADR-Autolus Therapeutics-NASDAQĪutolus Therapeutics focuses on T-cell therapies for cancer patients.Īstellas is a biotech company dealing with cancer, specifically bladder cancer. Stem Cell Stocks for 2021īelow is an list of all publicly traded stem cell stocks, listed alphabetically by their ticker symbol from “A” to “Z.” As you can see, there are nearly 40 publicly traded stem cell stocks for you to consider. Second, they can differentiate into specialized cell types, such as muscles cells, bloods cells, or brain cells, for example. Stem cells are the master cells in your body, and they can multiply in one of two ways. First, they can form more stem cells like themselves. Stem cells are also found in plants and animals. Stem cells are undifferentiated cells that have the capacity to both differentiate and multiply into the 200 cells types that form a human being. In total, the human body is composed of an estimated 30 trillion cells, making stem cells extremely important to human development. Given these conditions, an intriguing niche within biotech investing is stem cell stocks. Furthermore, stem cell companies have received substantial support for their use as living therapeutics against COVID-19 induced respiratory complications, such as ARDS.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |